Santen Pharmaceutical Co Ltd – Strategy, SWOT and Corporate Finance Report
- Pages: 52
- Published: July 2019
- Report Code: MLPH6375FSA
Santen Pharmaceutical Co Ltd – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360Ëš view of the company
Key Highlights
Santen Pharmaceutical Co Ltd (Santen) focuses on the research, development, manufacture and marketing of pharmaceutical products and medical devices. Its product portfolio includes prescription ophthalmic products for bacterial conjunctivitis, glaucoma, dry eye, inflammation and others; OTC ophthalmic products; anti-allergy ophthalmic products; and medical devices such as intraocular lenses (IOLs) and others. Santen operates through group companies in Asia, Europe and the US. The company’s R&D activities focus on the development of ophthalmic treatments. Santen is headquartered in Kita-ku, Osaka, Japan.
Scope
Detailed information on Santen Pharmaceutical Co Ltd required for business and competitor intelligence needs
A study of the major internal and external factors affecting Santen Pharmaceutical Co Ltd in the form of a SWOT analysis
An in-depth view of the business model of Santen Pharmaceutical Co Ltd including a breakdown and examination of key business segments
News about Santen Pharmaceutical Co Ltd, such as business expansion, restructuring, and contract wins
Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
Gain understanding of Santen Pharmaceutical Co Ltd and the factors that influence its strategies.Track strategic initiatives of the company and latest corporate news and actions.
Assess Santen Pharmaceutical Co Ltd as a prospective partner, vendor or supplier.
Support sales activities by understanding your customers' businesses better.
Stay up to date on Santen Pharmaceutical Co Ltds business structure, strategy and prospects.
Note: Some sections may be missing if data is unavailable for the company.
Companies mentioned
Taisho Pharmaceutical Holdings Co Ltd
Senju Pharmaceutical Co Ltd
Mitsubishi Tanabe Pharma Corp
Hoya Corp
Daiichi Sankyo Co Ltd
Chugai Pharmaceutical Co Ltd
Astellas Pharma Inc
Aqumen Biopharmaceuticals
Alcon Japan Ltd
Table of Contents
List of Tables
List of Figures
Pricing
Discounts available for multiple report purchases.